Literature DB >> 64874

Rectal valproate in intractable status epilepticus.

F J Vajda, G R Symington, P F Bladin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 64874     DOI： 10.1016/s0140-6736(77)91155-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Bioavailability of sodium valproate suppositories during repeated administration at steady state in epileptic children.

Authors:  J Issakainen; B F Bourgeois
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

Review 2.  Rectal drug administration: clinical pharmacokinetic considerations.

Authors:  A G de Boer; F Moolenaar; L G de Leede; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of valproic acid--1988.

Authors:  G Zaccara; A Messori; F Moroni
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

Review 4.  Practical Management of Epileptic Seizures and Status Epilepticus in Adult Palliative Care Patients.

Authors:  Wenke Grönheit; Stoyan Popkirov; Tim Wehner; Uwe Schlegel; Jörg Wellmer
Journal:  Front Neurol       Date:  2018-08-02       Impact factor: 4.003

Review 5.  Efficacy and safety of intravenous valproate for status epilepticus: a systematic review.

Authors:  Eugen Trinka; Julia Höfler; Alexander Zerbs; Francesco Brigo
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.